← Back to Search

Observational (specimen collection) for Neuroblastoma

N/A
Waitlist Available
Led By Tara O Henderson
Research Sponsored by Children's Oncology Group
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights

Summary

This research trial studies late effects after treatment in patients with previously diagnosed high-risk neuroblastoma. Studying late effects after treatment may help to decide which treatments for high-risk neuroblastoma are better tolerated with less side effects over time.

Eligible Conditions
  • Neuroblastoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pediatric Quality of Life (PedsQL) score
Prevalence of specific late effects
Risk factors of late effects
Secondary outcome measures
Collection and storage of blood samples

Trial Design

1Treatment groups
Experimental Treatment
Group I: Observational (specimen collection)Experimental Treatment3 Interventions
Patients undergo collection of blood and urine samples on day 1. Patients also undergo clinical assessments, laboratory, radiographic, and other ancillary studies on day 1.

Find a Location

Who is running the clinical trial?

Children's Oncology GroupLead Sponsor
457 Previous Clinical Trials
239,454 Total Patients Enrolled
63 Trials studying Neuroblastoma
31,500 Patients Enrolled for Neuroblastoma
National Cancer Institute (NCI)NIH
13,841 Previous Clinical Trials
41,002,439 Total Patients Enrolled
205 Trials studying Neuroblastoma
53,319 Patients Enrolled for Neuroblastoma
Tara O HendersonPrincipal InvestigatorChildren's Oncology Group
1 Previous Clinical Trials
1,875 Total Patients Enrolled
~46 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top